CAMETOR Trademark

Trademark Overview

On Wednesday, September 22, 2004, a trademark application was filed for CAMETOR with the United States Patent and Trademark Office. The USPTO has given the CAMETOR trademark a serial number of 76612463. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 12, 2013. This trademark is owned by Alizyme Therapeutics Limited. The CAMETOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of metabolic diseases and disorders including obesity and diabetes
cametor

General Information

Serial Number76612463
Word MarkCAMETOR
Filing DateWednesday, September 22, 2004
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 12, 2013
Registration Number3137577
Registration DateTuesday, September 5, 2006
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 13, 2006

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of metabolic diseases and disorders including obesity and diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 12, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNORGINE B.V.
Party Type32 - New Owner After Registration
Legal Entity Type11 - Company
AddressAMSTERDAM ZO 1101 CA
NL
Party NameNORGINE B.V.
Party Type31 - New Owner After Registration
Legal Entity Type11 - Company
AddressAMSTERDAM ZO 1101 CA
NL
Party NameAlizyme Therapeutics Limited
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressCambridge CB1 6GX
Party NameAlizyme Therapeutics Limited
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressCambridge CB1 6GX
Party NameAlizyme Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressCambridge CB1 6GX

Trademark Events

Event DateEvent Description
Friday, April 12, 2013CANCELLED SEC. 8 (6-YR)
Wednesday, November 18, 2009AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, November 11, 2009AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, January 11, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 11, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 9, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 5, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, June 13, 2006PUBLISHED FOR OPPOSITION
Wednesday, May 24, 2006NOTICE OF PUBLICATION
Wednesday, April 26, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 21, 2006ASSIGNED TO LIE
Thursday, April 20, 2006EXAMINERS AMENDMENT MAILED
Thursday, April 20, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 20, 2006EXAMINER'S AMENDMENT ENTERED
Thursday, April 20, 2006EXAMINERS AMENDMENT -WRITTEN
Monday, April 10, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, March 25, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 25, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 9, 2006NON-FINAL ACTION MAILED
Wednesday, March 8, 2006NON-FINAL ACTION WRITTEN
Wednesday, March 1, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 14, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 14, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 6, 2005LETTER OF SUSPENSION MAILED
Monday, September 5, 2005SUSPENSION LETTER WRITTEN
Thursday, September 1, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 22, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 22, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 25, 2005NON-FINAL ACTION MAILED
Friday, April 22, 2005NON-FINAL ACTION WRITTEN
Friday, April 22, 2005ASSIGNED TO EXAMINER
Friday, October 1, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

cametor including obesity diabetes disorders diseases preparations treatment metabolic pharmaceutical